Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in Capital	Accumulated Earnings	Accumulated Other Comprehensive Income (loss)
Beginning balances (in shares) at Dec. 31, 2021		283,257,104
Beginning balances at Dec. 31, 2021	$ 1,025,733	$ 722,430	$ 35,357	$ 267,666	$ 280
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		3,594,491
Shares issued and restricted stock units ("RSUs") vested under stock option plan	1,215	$ 11,935	(10,720)
Stock-based compensation expense	49,481		49,481
Foreign currency translation adjustment	(1,671)				(1,671)
Net earnings (loss)	158,519			158,519
Ending balances (in shares) at Dec. 31, 2022		286,851,595
Ending balances at Dec. 31, 2022	1,233,277	$ 734,365	74,118	426,185	(1,391)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		3,973,375
Shares issued and restricted stock units ("RSUs") vested under stock option plan	1,584	$ 18,834	(17,250)
Stock-based compensation expense	64,184		64,184
Foreign currency translation adjustment	(329)				(329)
Net earnings (loss)	(146,398)			(146,398)
Ending balances (in shares) at Dec. 31, 2023		290,824,970
Ending balances at Dec. 31, 2023	1,152,318	$ 753,199	121,052	279,787	(1,720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		4,932,032
Shares issued and restricted stock units ("RSUs") vested under stock option plan	1,700	$ 23,972	(22,272)
Stock-based compensation expense	67,581		67,581
Foreign currency translation adjustment	(2,658)				(2,658)
Net earnings (loss)	(162,857)			(162,857)
Ending balances (in shares) at Dec. 31, 2024		295,757,002
Ending balances at Dec. 31, 2024	$ 1,056,084	$ 777,171	$ 166,361	$ 116,930	$ (4,378)